Clinical Trial Update: Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP) [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic and dose–response study of asfotase alfa in adults with pediatric-onset hypophosphatasia completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• Asfotase alfa (asfotase alfa)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 2 | Status: COMPLETED | Results posted: 2018-07-10